The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
|Recipient||Amount||Start Date||End Date|
|New York Medical College||$ 1,500,000||   ||2010-09-01||2016-08-31|
|Yale University||$ 833,467||   ||2004-04-01||2009-03-31|
|$ 0||   |
|$ 0||   |
|$ 0||   |
|$ 0||   |
|$ 0||   |
|$ 0||   |
|$ 0||   |
|$ 0||   |
Fiscal Year 2016: In FY2016, one new cooperative agreement was awarded for Integrated Tick Management studies. Funding Opportunity Announcement no. CK16-002: Spatially scalable integrated tick vector/rodent reservoir management to reduce human risk of exposure to Ixodes scapularis ticks infected with Lyme disease spirochetes - Impact of single versus multi-property implementation in relation to human landscape use patterns and tick encounter locations. Fiscal Year 2017: In FY2017, it is expected that one cooperative agreement begun in FY2016 will be continued non-competitively. Fiscal Year 2018: In FY2018, it is expected that one cooperative agreement begun in FY2016 will be continued non-competitively.
Uses and Use Restrictions
Funding opportunities are made available to develop disease surveillance, conduct ecological and epidemiological studies, develop prevention and control activities, develop better diagnostic tests, and develop and disseminate educational materials and programs.
Cooperative Agreements include funds for direct costs, i.e., personnel, travel, equipment, supplies, necessary to carry out an approved project as well as funds for the reimbursement of applicable indirect costs.
Unallowable costs, such as reimbursement of pre-award costs, as well as those for which prior written approval is required, are indicated in the Health & Human Services (HHS) Grants Policy Statement (https://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf).
Public and nonprofit organizations able to provide services to geographical areas where Lyme disease is endemic or found to be newly emerging in the continental United States.
Thus, universities, colleges, research institutions, State and local health departments, and private nonprofit organizations are eligible.
States, political subdivisions of states, and other public and nonprofit private entities and the general public who may be exposed to the threat of Lyme disease in certain geographical areas.
Nonprofit organizations are corporations or associations no part of whose net earnings may lawfully inure to the benefit of any private shareholder or individual. Proof of nonprofit status must be submitted by private nonprofit organizations with the application or, if previously filed with PHS, the applicant must state where and when the proof was submitted. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.
Aplication and Award Process
This program has no preapplication requirements.
Environmental impact information is not required for this program.
This program is eligible for coverage under E.O.
12372, 'Intergovernmental Review of Federal Programs.' An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. To apply to a published funding opportunity, applications must be submitted electronically through Grants.gov (https://www.grants.gov) using the SF-424 Research and Related (R&R) forms and the SF-424 (R&R) Application Guide. Detailed application instructions are included in the Notice of Funding Opportunity (NOFO) for federal assistance. Online information can be found at HHS/CDC's Office of Financial Resources, Funding, Grants internet page: https://www.cdc.gov/grants/index.html. This program is subject to the provisions of 45 CFR 92 for State and local governments and OMB Circular No. A-110 for nonprofit organizations.
Upon receipt, applications will be evaluated for completeness and responsiveness by the HHS/CDC Office of Grant Services and agency extramural program office. HHS/CDC will not review incomplete and non-responsive applications. After review and approval, a notice of grant award (NoA) is prepared and processed, along with appropriate notification to the public. Initial award provides funds for first budget period (usually 12 months) and NoA indicates support recommended for the remainder of the period of performance, allocation of Federal funds by budget categories, and special conditions, if any.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Public Health Service Act, Section 301, 42 U.S.C 241(a).
Range of Approval/Disapproval Time
Approximately 3 to 6 months.
Cooperative agreement periods of performance are typically for 3 to 4 years. Subject to availability of funds, after initial awards, projects may be renewed non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Formula and Matching Requirements
This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.
Length and Time Phasing of Assistance
Assistance is available for a 12-month budget period within periods of performance typically ranging from 3 to 4 years. See the following for information on how assistance is awarded/released: After awards are issued, funds are released in accordance with the payment procedure established by the recipient institution with DHHS' payment management system (PMS). PMS will forward instructions to the recipient for obtaining payments.
Post Assistance Requirements
Program reports are not applicable.
Cash reports are not applicable.
The DHHS Public Health Service Non-Competing Continuation Progress Report (PHS 2590, Revised 03/2016) is due no later than 120 days prior to the end of each budget period within the period of performance.
This report also serves as the continuation application.
This report should include the information specified in the Notice of Funding Opportunity (NOFO).
The Annual Federal Financial Report (FFR, SF-425) is required and must be submitted through eRA Commons no later than 90 days after the end of the calendar quarter in which each budget period ends.
Final financial status reports are required no more than 90 days after the end of the period of performance.
Final performance reports are required no more than 90 days after the end of the project period.
All reports must be submitted to the Grants Management Specialist indicated in the NoA.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.
Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the end of a budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements.
(Cooperative Agreements (Discretionary Grants)) FY 16 $299,992; FY 17 est $500,000; and FY 18 est $500,000 - These obligations exclude federal assistance provided to the States through the Epidemiology and Laboratory Capacity (ELC) and Emerging Infections Program (EIP) cooperative agreements (covered under CFDA 93.283), and their supporting large contract(s) provided by program discretionary funds.
Range and Average of Financial Assistance
$250,000 to $500,000; Average award depends on Notice of Funding Opportunity (NOFO).
Regulations, Guidelines, and Literature
Information on DHHS Grants Policies and Regulations may be found at https://www.hhs.gov/grants/grants/grants-policies-regulations/index.html. Pertinent information may be obtained by contacting the Headquarters Office.
Regional or Local Office
See Regional Agency Offices. Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Office of Infectious Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521. Branch Extramural Activities Contacts: Ms. Diane Hamm - Telephone: (970) 221-6414 and Dr. Paul Mead - Telephone: (970) 221-6474. Division Extramural Activities Contacts: Ms. Lisa Mackey - Telephone: (970) 221-6415 or Dr. Charles (Ben) Beard - Telephone: (970) 221- 6418.
Christine Morrison 1600 Clifton Road, E60, Atlanta, Georgia 30329-4018 Email: CMorrison@cdc.gov Phone: 404-718-8845 Fax: 404-718-8640
Criteria for Selecting Proposals
Applications for public health research grants and cooperative agreements are evaluated for scientific and technical merit through the HHS/CDC peer review system. Applications are evaluated by a chartered Special Emphasis Panel in accordance with the Federal Advisory Committee Act, and in accordance with CDC peer review policy and manual. Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity (NOFO). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific merit by peer review, availability of funds, and relevance of program priorities and the priorities of DHHS. Refer to the NOFO for additional review criteria.
Cause Artist lists down the five health startups that are changing people’s views about health and wellness. These startups made use of their creative juices, and with tech know-how, have developed solutions to solve some of the world’s most complex health issues.